Literature DB >> 23293553

Hepatitis C virus and its renal manifestations: a review and update.

Nyan Latt1, Nada Alachkar, Ahmet Gurakar.   

Abstract

Hepatitis C virus (HCV) causes chronic systemic infection, primarily affecting the liver. Although HCV mainly causes hepatitis, a significant portion of chronic HCV patients manifests with at least 1 extrahepatic involvement during the course of their illness. Chronic HCV infection can cause various types of renal diseases. The most common renal manifestations of HCV infection are essential mixed cryoglobulinemia leading to membranoproliferative glomerulonephritis (MPGN), MPGN without cryoglobulinemia, and membranous glomerulonephritis. On the other hand, patients with end-stage kidney disease are at an increased risk of acquiring HCV due to their frequent exposure to potentially contaminated devices in dialysis units and their long-term use of vascular access. Among dialysis patients or patients undergoing renal transplantation, the presence of HCV is associated with higher rates of mortality. The optimal antiviral therapy in patients with severe renal insufficiency is not yet well established and, in most cases, is associated with serious adverse effects. Randomized controlled trials looking at treatment options are lacking. This article reviews the pathophysiology of renal manifestations of chronic HCV infection, discusses recent insights into diagnostic and treatment options for HCV-induced glomerulopathies and HCV-infected dialysis patients, and describes the work-up of HCV-positive renal transplant candidates.

Entities:  

Keywords:  Hepatitis C virus; glomerulonephritis; kidney transplantation; mixed cryoglobulinemia; renal manifestations

Year:  2012        PMID: 23293553      PMCID: PMC3533219     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  130 in total

1.  Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center.

Authors:  O Trejo; M Ramos-Casals; M García-Carrasco; J Yagüe; S Jiménez; G de la Red; R Cervera; J Font; M Ingelmo
Journal:  Medicine (Baltimore)       Date:  2001-07       Impact factor: 1.889

Review 2.  Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

Authors:  F Fabrizi; P Martin; V Dixit; S Bunnapradist; G Dulai
Journal:  Aliment Pharmacol Ther       Date:  2004-12       Impact factor: 8.171

3.  Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients.

Authors:  F Fabrizi; G Lunghi; V Dixit; P Martin
Journal:  Aliment Pharmacol Ther       Date:  2006-11-15       Impact factor: 8.171

4.  IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age.

Authors:  Grazia Malaponte; Valentina Bevelacqua; Pasquale Fatuzzo; Francesco Rapisarda; Giovanni Emmanuele; Salvatore Travali; Maria Clorinda Mazzarino
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

Review 5.  Management of hepatitis C virus-related mixed cryoglobulinemia.

Authors:  Francesco Iannuzzella; Augusto Vaglio; Giovanni Garini
Journal:  Am J Med       Date:  2010-05       Impact factor: 4.965

Review 6.  Glomerulonephritis.

Authors:  S J Chadban; R C Atkins
Journal:  Lancet       Date:  2005 May 21-27       Impact factor: 79.321

7.  Natural history of chronic hepatitis C in patients on hemodialysis: case control study with 4-23 years of follow-up.

Authors:  Kunio Okuda; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

8.  Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.

Authors:  Volker Schmitz; Anja Kiessling; Marcus Bahra; Gero Puhl; Andreas Kahl; Thomas Berg; Ruth Neuhaus; Peter Neuhaus; Ulf Neumann
Journal:  Ann Transplant       Date:  2007       Impact factor: 1.530

9.  Hepatitis C in chronic renal failure patients.

Authors:  A Mitwalli; S al-Mohaya; J al Wakeel; H el Gamal; V Rotimi; A al-Zeben; A al-Aska
Journal:  Am J Nephrol       Date:  1992       Impact factor: 3.754

Review 10.  Mixed cryoglobulinemia: a model of virus-related disease in internal medicine.

Authors:  Franco Dammacco; Gianfranco Lauletta; Michele Montrone; Domenico Sansonno
Journal:  Dig Liver Dis       Date:  2007-09       Impact factor: 4.088

View more
  22 in total

Review 1.  Management of patients with hepatitis C infection and renal disease.

Authors:  Chalermrat Bunchorntavakul; Monthira Maneerattanaporn; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Principles of separation: indications and therapeutic targets for plasma exchange.

Authors:  Mark E Williams; Rasheed A Balogun
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

3.  Synthesis and Evaluation of Bile Acid-Ribavirin Conjugates as Prodrugs to Target the Liver.

Authors:  Zhongqi Dong; Qing Li; Dong Guo; Yan Shu; James E Polli
Journal:  J Pharm Sci       Date:  2015-02-02       Impact factor: 3.534

Review 4.  Extrahepatic immune related manifestations in chronic hepatitis C virus infection.

Authors:  Maria Tampaki; John Koskinas
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

5.  Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection.

Authors:  Nicola Coppola; Federica Portunato; Antonio Riccardo Buonomo; Laura Staiano; Riccardo Scotto; Biagio Pinchera; Stefania De Pascalis; Daniela Caterina Amoruso; Salvatore Martini; Mariantonietta Pisaturo; Carmine Coppola; Ivan Gentile
Journal:  J Nephrol       Date:  2019-04-11       Impact factor: 3.902

6.  The incidence of possible causes of membranoproliferative glomerulonephritis: a single-center experience.

Authors:  J Pavinic; M Miglinas
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

Review 7.  Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.

Authors:  Carlo Palazzi; Emilio D'Amico; Salvatore D'Angelo; Michele Gilio; Ignazio Olivieri
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 8.  Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.

Authors:  Bruno Sangro; Stephen L Chan; Tim Meyer; María Reig; Anthony El-Khoueiry; Peter R Galle
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

Review 9.  Membranoproliferative glomerulonephritis, type II cryoglobulinemia and triple therapy for hepatitis C: a case series and review of the literature.

Authors:  Kevin Humphries; Jama M Darling; A Sidney Barritt
Journal:  Dig Dis Sci       Date:  2014-03-16       Impact factor: 3.487

Review 10.  Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.

Authors:  Nuria Montero; Alexandre Favà; Eva Rodriguez; Clara Barrios; Josep M Cruzado; Julio Pascual; Maria Jose Soler
Journal:  Cochrane Database Syst Rev       Date:  2018-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.